Ozempic and Anxiety: What the Mental Health Research Actually Shows

Maybe you started semaglutide for your blood sugar or your weight, and now you feel more on edge than usual. Or maybe you haven’t started yet, and the headlines about mood changes and suicidal thoughts have you hesitating. Either way, it’s a fair question, and you deserve an answer built on more than anecdotes.

GLP-1 is a natural hormone that helps regulate appetite and how much you eat. The Wegovy prescribing information notes that GLP-1 receptors are present in several brain areas involved in appetite. Semaglutide, the active drug in both Ozempic and Wegovy, is built to mimic natural GLP-1 with precision, sharing 94% of its structure. A medicine that acts in the brain should be checked for effects on mood.

For years, the main way to spot a medication’s psychiatric risks has been to collect reports from patients and clinicians. A European safety report analysis covering reports filed through mid-2023 found depression, anxiety, and suicidal thoughts among the psychiatric events reported with GLP-1 drugs, and European regulators investigated. This kind of monitoring is how rare risks get caught early. The system works, and it’s an essential first alarm.

But a report can’t show whether a drug caused a symptom or simply happened alongside it, and at Siggy we’d rather weigh the full body of evidence than react to the loudest signal.

Randomized trials and large matched cohort studies compare people taking semaglutide with similar people who aren’t, which is how you separate cause from coincidence. This guide walks through what those studies show for anxiety, depression, and suicidal thoughts, plus the side effects that can feel like anxiety and what to tell your prescribers. The answer comes from comparing like with like, which makes it a question of evidence.

What This Page Covers

• Why Would a Diabetes and Weight Drug Affect Mood?
• Does Ozempic Cause Anxiety?
• What About Depression and Suicidal Thoughts?
• Why Did Early Reports Raise Alarms?
• How Does the Evidence Stack Up?
• Could Semaglutide Help Anxiety or Depression?
• Which Side Effects Can Feel Like Anxiety?
• Can Ozempic Affect Your Psychiatric Medications?
• Who Should Be Watched Most Closely?
• How Siggy Fits In
• The Bottom Line on Ozempic and Mental Health
• Start Your Anonymous Intake

Why Would a Diabetes and Weight Drug Affect Mood?

The Ozempic prescribing information covers type 2 diabetes, while Wegovy, which contains the same drug, is approved for weight management. Either way, there are two reasons the mood question comes up. The first is biology: semaglutide reaches receptors in the brain, which is part of how it quiets appetite. The second is the people who take it. Weight and mood are closely linked, and a meta-analysis of longitudinal studies found the link runs both ways: obesity raised the odds of later depression by 55%, and depression raised the odds of later obesity by 58%.

That second point matters when you read about side effects. People with obesity or diabetes already carry a higher baseline risk of depression, so some mood changes will show up during treatment whether or not the drug plays a role. Good studies account for that, and reports alone usually can’t.

Does Ozempic Cause Anxiety?

The best current answer is no, not for most people. A 2026 meta-analysis of trials pooled 86 studies and 133,378 participants and found no significant difference in anxiety between GLP-1 medications and control treatments. The same analysis found no link with depression, suicide, sleep problems, or other psychiatric disorders, and results held across doses, treatment lengths, and reasons for use.

Anxiety also isn’t among the common side effects listed for adults on the Wegovy label. In the adolescent trial, anxiety was reported by 4% of teens on semaglutide and 2% on placebo, a small difference in a trial of about 200 participants.

Your anxiety is still real, and its cause may be something other than a direct effect on your brain, which is worth sorting out with your prescriber.

What About Depression and Suicidal Thoughts?

Here, the evidence has grown much more reassuring. In a pooled STEP trial analysis, 3,377 adults with overweight or obesity were tracked with standard depression and suicide questionnaires for 68 weeks. Semaglutide didn’t increase depressive symptoms or suicidal thoughts compared with placebo, and people taking it were less likely to shift into a more severe depression category. The small drop in depression scores wasn’t large enough to count as clinically meaningful. Several authors worked for the manufacturer, Novo Nordisk, which is worth knowing, though the questionnaires were collected in randomized, blinded trials.

A 2025 JAMA Psychiatry meta-analysis of 27 placebo-controlled trials found suicide and self-harm events were very rare in both groups, fewer than 0.05 per 100 person-years, with no significant difference between GLP-1 drugs and placebo. A large real-world cohort of 240,618 people with overweight or obesity found semaglutide was linked to a lower risk of new suicidal thoughts than other weight-loss medications. Observational studies like this can’t prove cause, but they point the same direction as the trials.

The current Wegovy prescribing information doesn’t include a warning about suicidal behavior or ideation. If you ever have thoughts of harming yourself, call 911 or call or text 988 right away, whatever medication you take.

Why Did Early Reports Raise Alarms?

The European safety database analysis reviewed 31,444 reports for semaglutide, liraglutide, and tirzepatide. Psychiatric events made up 1.2% of them, and among those, depression, anxiety, and suicidal thoughts were the most common. Nine reports involved deaths.

Those reports deserve to be taken seriously, and the authors called for further investigation. But a report database only counts events, with no comparison group, so it can’t show whether the drug caused them. Given how closely weight and depression are linked, some events would be expected in people taking these medicines even if the drugs had no effect on mood at all.

How Does the Evidence Stack Up?

Here’s how the main studies compare, from early safety signals to randomized and matched data.

Study Type	Who Was Studied	Main Finding
European safety reports	31,444 reports, no comparison group	Psychiatric events in 1.2% of reports
STEP trials, pooled	3,377 adults with overweight or obesity	No rise in depression or suicidal thoughts
Meta-analysis of 27 trials	About 59,000 adults	No rise in suicide or self-harm events
Meta-analysis of 86 trials	133,378 participants	No rise in anxiety or depression
Swedish national cohort	95,490 people with depression or anxiety	Lower risk of worsening with semaglutide

The pattern is consistent. The further a study goes to compare like with like, the less evidence there is of harm.

Could Semaglutide Help Anxiety or Depression?

Possibly, though it’s too early to call it a treatment. A 2026 Lancet Psychiatry study followed 95,490 people in Sweden who already had depression or anxiety and used diabetes medications. Comparing each person’s periods on and off treatment, semaglutide was linked to a 42% lower risk of their mental illness worsening, including a lower risk of worsening anxiety and of worsening depression.

Other data are more neutral. A 12-month matched cohort study of people with type 2 diabetes found semaglutide didn’t raise the risk of anxiety, depression, or suicidality compared with three other diabetes drugs. The Swedish authors called for randomized trials, and semaglutide isn’t approved for any psychiatric condition.

Which Side Effects Can Feel Like Anxiety?

Some of the most common side effects can mimic anxiety, especially early on. On the Wegovy label, 44% of adults on semaglutide reported nausea, compared with 16% on placebo, and stomach side effects were most frequent while the dose was being increased. Constant queasiness and eating much less than usual can leave you feeling drained and on edge.

Semaglutide also raised resting heart rate by about 1 to 4 beats per minute on average, and some people had larger jumps. The label tells patients to report palpitations or a racing heartbeat at rest, which many people would otherwise read as anxiety. For people with diabetes who also use insulin or a sulfonylurea, the label warns about low blood sugar, which can bring on symptoms that are easy to mistake for nerves.

If your anxiety started or spiked after a dose increase, note the timing and tell your prescriber. That pattern is useful information.

Can Ozempic Affect Your Psychiatric Medications?

Semaglutide slows how quickly your stomach empties. The label notes this may affect the absorption of other oral medicines and recommends closer monitoring for drugs that have a narrow safety margin or need regular checks. Lithium, which requires blood-level monitoring, is one example. Our guide to lithium toxicity symptoms explains why levels matter.

The practical step is simple: make sure the clinician treating your mood or anxiety knows you’re on a GLP-1 medication, and that the prescriber managing your GLP-1 knows your psychiatric medications. Also keep in mind that semaglutide lingers in the body for about 5 to 7 weeks after the last dose.

Who Should Be Watched Most Closely?

The STEP trials enrolled people without known major psychiatric conditions, and the JAMA Psychiatry review found that more than a third of the trials it analyzed excluded people with a history of psychiatric disorders or suicide attempts. That leaves less trial data for people with a history of depression, anxiety, or suicidal thoughts. Closer check-ins make sense if you:

• Have a past or current depressive or anxiety disorder
• Have ever had suicidal thoughts or a suicide attempt
• Are a teenager starting treatment
• Are in the dose-increase phase, when side effects peak

Closer monitoring is a reason to track your mood as carefully as your weight or blood sugar, not a reason to avoid semaglutide.

How Siggy Fits In

Whoever prescribes your GLP-1 medication, whether a primary care clinician, endocrinologist, or weight specialist, may not have time to focus on mood during those visits. That can leave you on your own when anxiety or low mood shows up in the middle of treatment.

Siggy prescribers treat anxiety and depression. You start with a free, anonymous intake, with no name or email required, where you can describe what you’re feeling and every medication you take, including semaglutide. A licensed prescriber reviews your intake before anything is prescribed, and you get a summary you can keep and share with the clinician who manages your GLP-1. Once you’re on a plan, Siggy is built to stay with you between appointments, so a new side effect or a change in how you feel doesn’t wait months to be noticed.

This article is for education and isn’t a substitute for care from a licensed clinician.

The Bottom Line on Ozempic and Mental Health

The early alarms about semaglutide and mental health were worth raising, and the research that followed has been largely reassuring. Large trials and matched studies don’t show a rise in anxiety, depression, or suicidal thoughts, and some data hint at a benefit for people who already live with depression or anxiety. Side effects like nausea and a faster heartbeat can still feel like anxiety, so new symptoms deserve a conversation, not a guess. If anxiety is part of the picture, our guide to the best anxiety medications covers the options a prescriber might discuss.

Start Your Anonymous Intake

If you’re in crisis or thinking about harming yourself, call 911 or call or text 988 first. If you’re taking a GLP-1 medication and your anxiety or mood has shifted, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with whoever manages your GLP-1.